• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Lilly oncology

Quote








lilly Oncology is dying. Will be dead sooner than later. There is a mass exodus about to begin. Should have seen it coming with all the ecp hires. Good luck to us all. Our leadership is terrible and all the good tenured folks are just waiting to get to whatever pints they need to retire.
 












anonymous said:
lilly Oncology is dying. Will be dead sooner than later. There is a mass exodus about to begin. Should have seen it coming with all the ecp hires. Good luck to us all. Our leadership is terrible and all the good tenured folks are just waiting to get to whatever pints they need to retire.
Click to expand...

Leadership = marketing gets credit for sales growth, sales takes hit for decline.
 




  • erparp   Dec 10, 2019 at 05:53: PM
anonymous said:
Management really showing how much they value Lilly oncology. Buy a company for billions and then let them take over. Amazing.

Cant say I blame them, really.
Click to expand...

Loxo micromanages everything they do for their ONE asset; give them a whole portfolio and see how they manage. What dirt does Loxo have on Anne and Dan anyway...they have completely caved to everything Loxo wants. If Loxo doesn't like something someone tells them, they run to Dan and bam! Dan gives them what they want. Completely demeaning and de-motivating for the Lilly employees working on oncology assets.
 




Top Bottom
Back
Quote